Suppr超能文献

拉科酰胺[(2R)-2-(乙酰氨基)-N-苄基-3-甲氧基丙酰胺]、利多卡因和卡马西平对感觉神经元电压门控钠通道的差异性阻断作用

Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.

作者信息

Sheets Patrick L, Heers Cara, Stoehr Thomas, Cummins Theodore R

机构信息

Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

J Pharmacol Exp Ther. 2008 Jul;326(1):89-99. doi: 10.1124/jpet.107.133413. Epub 2008 Mar 31.

Abstract

Voltage-gated sodium channels play a critical role in excitability of nociceptors (pain-sensing neurons). Several different sodium channels are thought to be potential targets for pain therapeutics, including Na(v)1.7, which is highly expressed in nociceptors and plays crucial roles in human pain and hereditary painful neuropathies, Na(v)1.3, which is up-regulated in sensory neurons following chronic inflammation and nerve injury, and Na(v)1.8, which has been implicated in inflammatory and neuropathic pain mechanisms. We compared the effects of lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], a new pain therapeutic, with those of lidocaine and carbamazepine on recombinant Na(v)1.7 and Na(v)1.3 currents and neuronal tetrodotoxin-resistant (Na(v)1.8-type) sodium currents using whole-cell patch-clamp electrophysiology. Lacosamide is able to substantially reduce all three current types. However, in contrast to lidocaine and carbamazepine, 1 mM lacosamide did not alter steady-state fast inactivation. Inhibition by lacosamide exhibited substantially slower kinetics, consistent with the proposal that lacosamide interacts with slow-inactivated sodium channels. The estimated IC(50) values for inhibition by lacosamide of Na(v)1.7-, Na(v)1.3-, and Na(v)1.8-type channels following prolonged inactivation were 182, 415, and 16 microM, respectively. Na(v)1.7-, Na(v)1.3-, and Na(v)1.8-type channels in the resting state were 221-, 123-, and 257-fold less sensitive, respectively, to lacosamide than inactivated channels. Interestingly, the ratios of resting to inactivated IC(50)s for carbamazepine and lidocaine were much smaller (ranging from 3 to 16). This suggests that lacosamide should be more effective than carbamazepine and lidocaine at selectively blocking the electrical activity of neurons that are chronically depolarized compared with those at more normal resting potentials.

摘要

电压门控钠通道在伤害感受器(痛觉感受神经元)的兴奋性中起关键作用。几种不同的钠通道被认为是疼痛治疗的潜在靶点,包括在伤害感受器中高度表达且在人类疼痛和遗传性疼痛性神经病变中起关键作用的Na(v)1.7、在慢性炎症和神经损伤后感觉神经元中上调的Na(v)1.3以及与炎症性和神经性疼痛机制有关的Na(v)1.8。我们使用全细胞膜片钳电生理学方法,比较了新型疼痛治疗药物拉科酰胺[(2R)-2-(乙酰氨基)-N-苄基-3-甲氧基丙酰胺]与利多卡因和卡马西平对重组Na(v)1.7和Na(v)1.3电流以及神经元河豚毒素抗性(Na(v)1.8型)钠电流的影响。拉科酰胺能够显著降低所有三种电流类型。然而,与利多卡因和卡马西平不同的是,1 mM拉科酰胺不会改变稳态快速失活。拉科酰胺的抑制表现出明显更慢的动力学,这与拉科酰胺与慢失活钠通道相互作用的提议一致。长时间失活后,拉科酰胺对Na(v)1.7型、Na(v)1.3型和Na(v)1.8型通道抑制的估计IC(50)值分别为182、415和16 microM。静息状态下的Na(v)1.7型、Na(v)1.3型和Na(v)1.8型通道对拉科酰胺的敏感性分别比失活通道低221倍、123倍和257倍。有趣的是,卡马西平和利多卡因的静息与失活IC(50)的比值要小得多(范围为3至16)。这表明与处于更正常静息电位的神经元相比,拉科酰胺在选择性阻断长期去极化的神经元的电活动方面应该比卡马西平和利多卡因更有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验